糖尿病多神经病的脂质载体ABCA1:通过循环代谢物的潜在调解
Yan Cao1,2, Yuyan Pan1, Yan Yan3
1Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Journal of pain research
|October 13, 2025
概括
这是一个很大的问题.
科学领域:
- 遗传学和分子生物学
- 代谢障碍 代谢障碍 代谢障碍
- 神经学 神经学
背景情况:
- 糖尿病多神经病 (DPN) 是一种导致神经损伤和疼痛的糖尿病并发症.
- DPN与脂质障碍症有关,而Probucol显示出糖尿病和疼痛管理的潜力.
- 普罗布科尔对DPN和脂质不良症的具体影响尚不清楚.
研究的目的:
- 研究循环代谢物在Probucol目标基因ABCA1和DPN之间的关系中的调解作用.
- 探索Probucol对DPN的潜在治疗作用的遗传基础.
主要方法:
- 采用了两步的门德尔随机化研究.
- 基因仪器使用低密度脂蛋白 (LDL) 作为阳性对照进行了验证.
- 逆变量加权 (IVW) 和MR-Egger回归被用于分析,包括异质性和灵敏性测试.
主要成果:
- 基因预测的ABCA1与增加的LDL和四种循环代谢物有关.
- 观察到ABCA1对DPN的直接遗传影响 (0.3006).
- 四种代谢物HDL粒子直径,中等LDL总胆固醇,中等VLDL甘油三和非常大的HDL自由胆固醇部分调解了ABCA1-DPN关联.
结论:
- 这项研究为ABCA1,代谢物和DPN之间的关联提供了遗传证据.
- ABCA1对DPN有直接影响,具有重要的调解途径,涉及四种循环代谢物.
- 这些发现支持Probucol在预防和治疗DPN方面的潜在机制.
相关概念视频
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
166
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
166
ABC Transporters: Exporter
6.3K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Nonlinear Pharmacokinetics: Role of Transporters
279
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
279

